瑞思迈作为全球数字健康和云连接医疗设备的领导者，通过改变对睡眠呼吸暂 停、慢性阻塞性肺疾病和其他慢性病患者的治疗和护理，减少了慢性疾病的影响，  降低了消费者及医保系统的成本。30年间，瑞思迈深耕呼吸睡眠领域， 已改善全球 1.78亿呼吸慢病患者生活质量。公司在美国和澳大利亚双重上市， 2021年起位列胡 润世界500强。瑞思迈全球拥有超过1万名员工、超过9300项专利，产品远销140多个国家。瑞思迈注重呼吸机医疗数字化，通过自主研发AirView 产品，有效解决医生 和服务商为患者提供精准化远程服务的问题。

ResMed, a global leader in digital health and cloud-connected medical devices, works to reduce the impact of chronic diseases and lower costs for both consumers and healthcare systems by transforming the treatment and care of patients with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic conditions. Over its 30-year journey in respiratory and sleep medicine, ResMed has improved the quality of life for 178 million patients worldwide with chronic respiratory conditions.

地址：北京市顺义区天竺地区府前一街13号4幢4层403室
Room 403, 4F, Building 4, No.13, Fuqianyi Street, Tianzhu Area, Shunyi District, Beijing, China
电话：13681053470